This study aims at understanding the knowledge and preferences of Kenyan Gay and Bi-sexual MSM (GBMSM) and transgender women regarding the use of oral PrEP. URCHOICE is a one-year multisite study targeting MSM on the preferred options for taking oral PrEP.
Objectives
- The study intends to determine the preferences of men who have sex with men (MSM) towards reduce their risk of acquiring HIV in Kenya i.e. their use of condoms, daily oral pre-exposure prophylaxis (PrEP), or use of prolonged acting PrEP.
Project Initiated 2021
The one-year study began in May 2021. It intends to target 150 GBMSM at each site and 500 across all three sites. The interview data was used to assess discrete choices between possible prevention options, reasons for different choices, and potential challenges in promoting the various PrEP options, through focus group discussions.
The study saw participation from 146 out of the 150 enrolled members for the information sessions and 98 out of the 140 enrolled participants for the interviews.
Partnerships
PHDA partners with the University of Illinois, Chicago, with funding from Merck, Sharp and Dohme.